🇺🇸 FDA
Patent

US 9403839

Pyran-spirocyclic piperidine amides as modulators of ion channels

granted A61PA61P1/12A61P13/10

Quick answer

US patent 9403839 (Pyran-spirocyclic piperidine amides as modulators of ion channels) held by Vertex Pharmaceuticals Incorporated expires Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Aug 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61P, A61P1/12, A61P13/10, A61P19/02, A61P21/02